IRIS - Res&Arch Institutional Research Information System - Research & Archive

SCHIAROLI, ELISABETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.494
EU - Europa 953
AS - Asia 435
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
Totale 2.889
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.485
IE - Irlanda 364
IT - Italia 281
SG - Singapore 141
HK - Hong Kong 132
CN - Cina 109
UA - Ucraina 52
RU - Federazione Russa 51
SE - Svezia 45
VN - Vietnam 39
GB - Regno Unito 35
FI - Finlandia 34
DE - Germania 26
FR - Francia 19
BE - Belgio 11
CH - Svizzera 9
CA - Canada 8
AT - Austria 7
NL - Olanda 7
TR - Turchia 6
PL - Polonia 4
CL - Cile 2
CZ - Repubblica Ceca 2
ES - Italia 2
GR - Grecia 2
IN - India 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BR - Brasile 1
CO - Colombia 1
DK - Danimarca 1
EU - Europa 1
ID - Indonesia 1
IQ - Iraq 1
IR - Iran 1
LB - Libano 1
MX - Messico 1
PH - Filippine 1
RO - Romania 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 2.889
Salva come PNG Salva come JPEG
Città #
Dublin 364
Chandler 310
San Mateo 163
Hong Kong 132
Altamura 112
Dearborn 94
Perugia 92
Singapore 85
Medford 81
Princeton 81
Lawrence 78
Ann Arbor 55
Wilmington 53
Andover 49
Dong Ket 39
Beijing 36
Falls Church 30
Redmond 22
Des Moines 21
Saint Petersburg 17
Los Angeles 16
New York 16
San Paolo di Civitate 14
Norwalk 13
Helsinki 12
Jacksonville 12
Brussels 11
Florence 10
Woodbridge 9
Bastia umbra 8
Rome 8
Ottawa 7
Redwood City 7
Houston 6
Izmir 6
Hefei 5
Moscow 5
Nanjing 5
Nanning 5
Ningbo 5
Chicago 4
Den Haag 4
Jinan 4
Kunming 4
Vienna 4
Ashburn 3
Lappeenranta 3
Tappahannock 3
Amsterdam 2
Blanes 2
Boardman 2
Cambridge 2
Fairfield 2
Guangzhou 2
Lausanne 2
London 2
Menlo Park 2
Milan 2
Nanchang 2
Naples 2
Pianello Val Tidone 2
San Diego 2
Shanghai 2
Sinalunga 2
Trieste 2
West Jordan 2
Aachen 1
Alcamo 1
Bari 1
Basra 1
Bisaccia 1
Bogotá 1
Bologna 1
Brescia 1
Bryanston 1
Edinburgh 1
Falkenstein 1
Favara 1
Figline Valdarno 1
Grimmen 1
Groningen 1
Jakarta 1
Kashan 1
Kiev 1
Landshut 1
Liberty 1
Ludwigshafen am Rhein 1
Nagold 1
Olomouc 1
Radeberg 1
Santa Clara 1
Seattle 1
Shenyang 1
Shenzhen 1
São Bernardo do Campo 1
Timisoara 1
Toronto 1
Zhengzhou 1
Totale 2.191
Salva come PNG Salva come JPEG
Nome #
Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice. 85
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 74
Effects of antiretroviral therapy on lipid and immunovirological profile: Focus on proprotein convertase subtilisin/kexin 9 63
Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) 62
Management of Hepatitis B Virus Reactivation in Patients with Hematological Malignancies Treated with Chemotherapy. 60
Effect of aspirin treatment on abacavir-associated platelet hyperreactivity in HIV-infected patients 60
A nutraceutical combination targeting dyslipidemia and subclinical inflammation in HIV patients on stable antiretroviral therapy 58
Leflunomide protects against dyslipidemia development induced by ritonavir in mice 53
Awareness, discussion and non-prescribed use of HIV pre-exposure prophylaxis among persons living with HIV/AIDS in Italy: A Nationwide, cross-sectional study among patients on antiretrovirals and their treating HIV physicians 53
Ritonavir-induced lipoatrophy and dyslipidaemia is reversed by the anti-inflammatory drug leflunomide in a PPAR-γ-dependent manner. 52
Maraviroc Intensification Modulates Atherosclerotic Progression in HIV-Suppressed Patients at High Cardiovascular Risk. A Randomized, Crossover Pilot Study 52
Clusterization of co-morbidities and multi-morbidities among persons living with HIV: A cross-sectional study 52
Smoking Habits in Human Immunodeficiency Virus-Infected People from Italy: A Cross-Sectional Analysis of the STOPSHIV Cohort 51
Bile acid activated receptors are targets for regulation of integrity of gastrointestinal mucosa 50
The HIV Matrix Protein p17 subverts Nuclear Receptors Expression and induces a STAT1-Dependent Proinflammatory Phenotype in Monocytes 49
Biochemical markers of bone turnover and calcium dietary intake evaluation in HIV-infected patients 47
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 46
Reactivation of hepatitis B virus replication due to cytotoxic therapy:a five-year prospective study 45
Partial achievement of the 90-90-90 UNAIDS target in a cohort of HIV infected patients from Central Italy 45
The HIV Matrix Protein p17 promotes the Activation of human hepatic stellate cells through interactions with CXCR2 and Syndecan-2 44
Diagnosis of Nocardia paucivorans central nervous system infection by DNA sequencing from paraffin-embedded tissue 44
Impact of SARS-CoV-2 Omicron variants on serum neutralization in a cohort of healthcare workers vaccinated with BNT162b2 42
Bone-turnover markers in white HIV-infected patiens treated with or without TDF-containg regimens 42
Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virus 41
Seroprevalence of anti-SARS-CoV2 antibodies in umbrian persons living with HIV 41
Cross-neutralization of SARS-CoV-2 B.1.1.7 and P.1 variants in vaccinated, convalescent and P.1 infected 41
Percutaneous vertebroplasty improves pain control and quality of life in patients suffering from back pain: A single center experience 40
Carbapenemase-producing Enterobacteriaceae isolates resistant to last-line antibiotics in an Italian general hospital. 39
The association between neutrophil to lymphocyte ratio and endothelial dysfunction in people living with HIV on stable antiretroviral therapy 39
Effects of antiretroviral therapy on proprotein convertase subtilisin/kexin 9: focus on lipids, inflammation and immunovirological parameters 38
Gangrenous Chickenpox with Atypical Clinical and Histopathological Findings. 36
Meningitis with cranial polyneuritis and cavernous sinus thrombosis by Borrelia crocidurae: First autochthonous case in Europe 36
Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data from the PRESTIGIO Registry 36
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 35
Predictive risk factors for worse outcomes in COVID-19 patients with different clinical features at baseline 35
Protective role of a tmprss2 variant on severe covid-19 outcome in young males and elderly women 35
Tedizolid-Rifampicin Combination Prevents Rifampicin-Resistance on in vitro Model of Staphylococcus aureus Mature Biofilm 34
Lingual tubercolosis: a rare disease in western countries 33
NUtraceutical TReatment for hYpercholesterolemia in HIV-infected patients: The NU-TRY(HIV) randomized cross-over trial 33
Role of pretreatment variables on plasma HIV RNA value at the sixth month of antiretroviral therapy including all first line drugs in HIV naïve patients: A path analysis approach 33
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort 33
Prevalence of smoking and nicotine dependence in HIV patients, the project STOPS HIV from Italy 32
Epidemiology and Microbiology of Skin and Soft Tissue Infections: Preliminary Results of a National Registry 32
Genetic mechanisms of critical illness in COVID-19 32
Predictive factors and prevalence of microalbuminuria in HIV-infected patients: A cross-sectional analysis 31
Is the rate of virological failure to cART continuing to decline in recent calendar years? 31
Comorbidities, cardiovascular therapies, and COVID-19 mortality: A nationwide, italian observational study (ItaliCO) 31
Low brachial artery flow-mediated dilation predicts worse prognosis in hospitalized patients with covid-19 31
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity 31
Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality 31
Urinary albumin-to-creatinine ratio is associated with endothelial dysfunction in HIV-infected patients receiving antiretroviral therapy 30
Validation of a self-reported HIV symptoms list: The ISS-HIV symptoms scale 30
Development of an internally controlled quantitative PCR to measure total cell-associated HIV-1 DNA in blood 30
The HIV matrix protein p17 induces hepatic lipid accumulation via modulation of nuclear receptor transcriptoma 29
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014 29
Role of nucleocapsid protein antigen detection for safe end of isolation of sars-cov-2 infected patients with long persistence of viral rna in respiratory samples 29
HIV-1 infection is associated with changes in nuclear receptor transcriptome, pro-inflammatory and lipid profile of monocytes 28
Role of Maraviroc in a dyslipidemic murine model of atherosclerosis RTV-induced 28
HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects From the ICONA Italian Cohort of HIV-Infected Patients 28
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study 28
Early treatment with bamlanivimab alone does not prevent COVID-19 hospitalization and its post-acute sequelae. A real experience in Umbria, Italy 28
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART 26
Durability of first-line regimens including integrase strand transfer inhibitors (INSTIs): data from a real-life setting 26
The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort 26
Management of Meningitis Caused by Multi Drug-Resistant Acinetobacter Baumannii: Clinical, Microbiological and Pharmacokinetic Results in a Patient Treated with Colistin Methanesulfonate 25
Elevated serum uric acid levels are associated with endothelial dysfunction in HIV patients receiving highly-active antiretroviral therapy 25
Evaluation of HIV transmission clusters among natives and foreigners living in Italy 25
Human immunodeficiency virus continuum of care in 11 european union countries at the end of 2016 overall and by key population: Have we made progress? 24
Effect of directly acting antivirals for hepatitis C virus infection on proprotein convertase subtilisin/kexin type 9 level 24
The Combination of Molnupiravir with Nirmatrelvir or GC376 Has a Synergic Role in the Inhibition of SARS-CoV-2 Replication In Vitro 23
Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D Study 23
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study 22
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 22
Hepatitis C virus and proprotein convertase subtilisin/kexin type 9: a detrimental interaction to increase viral infectivity and disrupt lipid metabolism 21
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort 21
Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research 21
Transgender people living with HIV: characteristics and comparison to homosexual and heterosexual cisgender patients in two Italian teaching hospitals 20
Pre and Post-Monoclonal Infusion Neutralizing Activity in a Subgroup of Patients Treated in the Presence of two SARS-CoV-2 Dominant Variant of Concern (VOCs) and an Ongoing Vaccination. Overall Clinical Efficacy of Two Monoclonal Antibodies Association in Umbria 19
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 19
An explainable model of host genetic interactions linked to COVID-19 severity 16
Epidemiology, aetiology and treatment of skin and soft tissue infections: final report of a prospective multicentre national registry 16
Stabilization of the Dimeric State of SARS-CoV-2 Main Protease by GC376 and Nirmatrelvir 16
Nelfinavir: An Old Ally in the COVID-19 Fight? 15
Mapping the human genetic architecture of COVID-19 15
Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19 14
Whole-genome sequencing reveals host factors underlying critical COVID-19 13
BNT162b2 Elicited an Efficient Humoral Response Against Different Strains of SARS-CoV-2 in People Living with HIV 13
Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy: A multinational prospective cohort study 13
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 12
Impaired neutralizing antibody efficacy of tixagevimab-cilgavimab 150+150 mg as pre-exposure prophylaxis against Omicron BA.5. A real-world experience in booster vaccinated immunocompromised patients 12
Efficacy of Licensed Monoclonal Antibodies and Antiviral Agents against the SARS-CoV-2 Omicron Sublineages BA.1 and BA.2 11
Impact of SARS-CoV-2 omicron and delta sub-lineage AY.4.2 variant on neutralization by sera of patients treated with different licensed monoclonal antibodies 11
The hope and hype of ellagic acid and urolithins as ligands of SARS-CoV-2 Nsp5 and inhibitors of viral replication 9
Prolonged higher dose methylprednisolone vs. conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS) 9
Tixagevimab/Cilgavimab: Still a Valid Prophylaxis against COVID-19 New Variants? 9
Determinants of worse liver-related outcome according to HDV infection among HBsAg positive persons living with HIV: Data from the ICONA cohort 8
Synergistic Activity of Remdesivir–Nirmatrelvir Combination on a SARS-CoV-2 In Vitro Model and a Case Report 8
The association between neutrophil to lymphocyte ratio and endothelial dysfunction in people living with HIV on stable antiretroviral therapy 6
Bictegravir/Tenofovir Alafenamide/Emtricitabine: A Real-Life Experience in People Living with HIV (PLWH) 3
Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort 2
Totale 3.129
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.709
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.709
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 0 0 0 1
2019/2020320 40 12 10 5 22 62 64 14 28 49 5 9
2020/2021266 3 7 11 13 119 8 9 21 21 6 8 40
2021/2022649 29 115 5 12 27 17 14 175 30 46 92 87
2022/20231.231 86 263 17 108 91 101 9 36 463 0 34 23
2023/2024509 26 71 20 8 7 3 133 5 30 27 99 80
Totale 3.133